Dow Up0.44% Nasdaq Up0.30%

Sunesis Pharmaceuticals, Inc. (SNSS)

0.47 Down 0.01(1.65%) 2:53PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.3
Mean Recommendation (last week):2.3

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:2.50
Median Target:2.50
High Target:2.50
Low Target:2.50
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jul 24, 2015Cantor FitzgeraldDowngradeBuyHold
Jul 24, 2015ROTH CapitalDowngradeBuySell
Dec 15, 2014ROTH CapitalUpgradeNeutralBuy
Oct 7, 2014RBC Capital MktsDowngradeOutperformSector Perform
Oct 7, 2014ROTH CapitalDowngradeBuyNeutral
Jun 12, 2014UBSInitiated Buy
May 29, 2012RBC Capital MktsUpgradeSector PerformOutperform
Apr 13, 2012Cantor FitzgeraldInitiated Buy
Mar 6, 2012Canaccord GenuityInitiated Buy
Oct 11, 2011RBC Capital MktsDowngradeOutperformSector Perform

More Upgrades & Downgrades for SNSS

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111

Data provided by Thomson/First Call

Currency in USD.